Arto Leminen

7.1k total citations
38 papers, 1.2k citations indexed

About

Arto Leminen is a scholar working on Reproductive Medicine, Obstetrics and Gynecology and Surgery. According to data from OpenAlex, Arto Leminen has authored 38 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Reproductive Medicine, 12 papers in Obstetrics and Gynecology and 10 papers in Surgery. Recurrent topics in Arto Leminen's work include Ovarian cancer diagnosis and treatment (31 papers), Endometrial and Cervical Cancer Treatments (9 papers) and Endometriosis Research and Treatment (7 papers). Arto Leminen is often cited by papers focused on Ovarian cancer diagnosis and treatment (31 papers), Endometrial and Cervical Cancer Treatments (9 papers) and Endometriosis Research and Treatment (7 papers). Arto Leminen collaborates with scholars based in Finland, United States and Netherlands. Arto Leminen's co-authors include Ralf Bützow, Annika Riska, Leila Unkila‐Kallio, Markku Heikinheimo, Mikko Anttonen, Jorma Paavonen, Heini Lassus, ­Eero Pukkala, Anniina Färkkilä and Pentti Lehtovirta and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Clinical Endocrinology & Metabolism and Clinical Cancer Research.

In The Last Decade

Arto Leminen

38 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Arto Leminen Finland 23 628 348 304 270 249 38 1.2k
Jamal Rahaman United States 18 571 0.9× 315 0.9× 252 0.8× 522 1.9× 163 0.7× 52 1.3k
Hanoch Levavi Israel 18 393 0.6× 326 0.9× 221 0.7× 219 0.8× 237 1.0× 58 1.1k
Annika Auranen Finland 23 930 1.5× 376 1.1× 385 1.3× 492 1.8× 316 1.3× 72 1.6k
Abbie L. Fields United States 19 454 0.7× 272 0.8× 325 1.1× 488 1.8× 318 1.3× 43 1.2k
S. Pecorelli Italy 4 895 1.4× 224 0.6× 456 1.5× 460 1.7× 284 1.1× 4 1.2k
Frédéric Buxant Belgium 16 486 0.8× 175 0.5× 142 0.5× 326 1.2× 264 1.1× 49 1.1k
Antonio Santillan United States 21 880 1.4× 440 1.3× 676 2.2× 469 1.7× 290 1.2× 27 1.6k
A Fanucchi Italy 24 833 1.3× 267 0.8× 390 1.3× 631 2.3× 420 1.7× 64 1.6k
Kuan-Chong Chao Taiwan 18 310 0.5× 167 0.5× 253 0.8× 400 1.5× 121 0.5× 61 923
Masamichi Hiura Japan 16 705 1.1× 184 0.5× 251 0.8× 750 2.8× 198 0.8× 50 1.2k

Countries citing papers authored by Arto Leminen

Since Specialization
Citations

This map shows the geographic impact of Arto Leminen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arto Leminen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arto Leminen more than expected).

Fields of papers citing papers by Arto Leminen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arto Leminen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arto Leminen. The network helps show where Arto Leminen may publish in the future.

Co-authorship network of co-authors of Arto Leminen

This figure shows the co-authorship network connecting the top 25 collaborators of Arto Leminen. A scholar is included among the top collaborators of Arto Leminen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arto Leminen. Arto Leminen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Andersson, Noora, Bhagwan Yadav, Anniina Färkkilä, et al.. (2017). Systematic drug sensitivity testing reveals synergistic growth inhibition by dasatinib or mTOR inhibitors with paclitaxel in ovarian granulosa cell tumor cells. Gynecologic Oncology. 144(3). 621–630. 27 indexed citations
2.
Färkkilä, Anniina, Noora Andersson, Ralf Bützow, et al.. (2014). HER2 and GATA4 are new prognostic factors for early‐stage ovarian granulosa cell tumor—a long‐term follow‐up study. Cancer Medicine. 3(3). 526–536. 28 indexed citations
3.
Färkkilä, Anniina, Ralf Bützow, Arto Leminen, et al.. (2014). Clinical Characteristics and Survival of Patients With an Adult-Type Ovarian Granulosa Cell Tumor A 56-Year Single-Center Experience. International Journal of Gynecological Cancer. 25(1). 33–41. 51 indexed citations
4.
Leminen, Arto, Annika Auranen, Ralf Bützow, et al.. (2012). [Update on current care guidelines: ovarian cancer].. PubMed. 128(12). 1300–1. 3 indexed citations
5.
Böckelman, Camilla, Heini Lassus, Annabrita Hemmes, et al.. (2011). Prognostic role of CIP2A expression in serous ovarian cancer. British Journal of Cancer. 105(7). 989–995. 83 indexed citations
6.
Färkkilä, Anniina, Mikko Anttonen, Arto Leminen, et al.. (2010). Vascular endothelial growth factor (VEGF) and its receptor VEGFR-2 are highly expressed in ovarian granulosa cell tumors. European Journal of Endocrinology. 164(1). 115–122. 36 indexed citations
7.
Riska, Annika & Arto Leminen. (2008). Determinants of Incidence of Primary Fallopian Tube Carcinoma (PFTC). Methods in molecular biology. 472. 387–396. 16 indexed citations
8.
Kyrönlahti, Antti, Leila Unkila‐Kallio, Ralf Bützow, et al.. (2008). GATA-4 Regulates Bcl-2 Expression in Ovarian Granulosa Cell Tumors. Endocrinology. 149(11). 5635–5642. 58 indexed citations
9.
Kuoppala, Tapio, Arto Leminen, Marja Komulainen, et al.. (2007). Surgical staging, treatment, and follow‐up of borderline tumors in different hospital categories: a prospective nationwide survey in Finland. Acta Obstetricia Et Gynecologica Scandinavica. 86(5). 610–614. 13 indexed citations
10.
Riska, Annika, Patrik Finne, Pentti Koskela, et al.. (2007). Human papillomavirus infection and primary fallopian tube carcinoma: a seroepidemiological study. BJOG An International Journal of Obstetrics & Gynaecology. 114(4). 425–429. 9 indexed citations
11.
Kuoppala, Tapio, Arto Leminen, Jorma Penttinen, et al.. (2006). Surgical treatment of ovarian cancer in different hospital categories – A prospective nation-wide study in Finland. European Journal of Cancer. 42(3). 388–395. 33 indexed citations
12.
Grénman, Seija, Tom Wiklund, Jyrki Jalkanen, et al.. (2006). A randomised phase III study comparing high-dose chemotherapy to conventionally dosed chemotherapy for stage III ovarian cancer: The Finnish Ovarian Cancer (FINOVA) study. European Journal of Cancer. 42(14). 2196–2199. 13 indexed citations
13.
Mannisto, Susanna, et al.. (2005). Transcription Factors GATA-4 and GATA-6, and their Potential Downstream Effectors in Ovarian Germ Cell Tumors. Tumor Biology. 26(5). 265–273. 10 indexed citations
14.
Anttonen, Mikko, Leila Unkila‐Kallio, Arto Leminen, Ralf Bützow, & Markku Heikinheimo. (2005). High GATA-4 Expression Associates with Aggressive Behavior, whereas Low Anti-Müllerian Hormone Expression Associates with Growth Potential of Ovarian Granulosa Cell Tumors. The Journal of Clinical Endocrinology & Metabolism. 90(12). 6529–6535. 60 indexed citations
15.
Mäenpää, Johanna, Seija Grénman, Jyrki Jalkanen, et al.. (2005). Sequential gemcitabine–carboplatin followed by paclitaxel–carboplatin in the first-line treatment of advanced ovarian cancer: A phase II study. Gynecologic Oncology. 101(1). 114–119. 4 indexed citations
16.
Lassus, Heini, Arto Leminen, Johan Lundin, Pentti Lehtovirta, & Ralf Bützow. (2003). Distinct subtypes of serous ovarian carcinoma identified by p53 determination☆☆☆☆☆Supplementary data associated with this article can be found at doi: 10.1016/S0090-8258(03)00608-5. Gynecologic Oncology. 91(3). 504–512. 59 indexed citations
17.
Riska, Annika, Arto Leminen, & ­Eero Pukkala. (2003). Sociodemographic determinants of incidence of primary fallopian tube carcinoma, Finland 1953–97. International Journal of Cancer. 104(5). 643–645. 59 indexed citations
18.
Unkila‐Kallio, Leila, Arto Leminen, Aila Tiitinen, & Olavi Ylikorkala. (1998). Nationwide data on falling incidence of ovarian granulosa cell tumours concomitant with increasing use of ovulation inducers. Human Reproduction. 13(10). 2828–2830. 17 indexed citations
19.
Lehtovirta, P, et al.. (1994). Tumour-associated trypsin inhibitor (TATI): comparison with CA125 as a preoperative prognostic indicator in advanced ovarian cancer. British Journal of Cancer. 70(6). 1188–1190. 27 indexed citations
20.
Cacciatore, Bruno, et al.. (1992). Transvaginal sonographic findings in ambulatory patients with suspected pelvic inflammatory disease.. PubMed. 80(6). 912–6. 70 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jamal Rahaman Breakdown of academic impact, for papers by Hanoch Levavi Breakdown of academic impact, for papers by Annika Auranen Breakdown of academic impact, for papers by Abbie L. Fields Breakdown of academic impact, for papers by S. Pecorelli Breakdown of academic impact, for papers by Frédéric Buxant Breakdown of academic impact, for papers by Antonio Santillan Breakdown of academic impact, for papers by A Fanucchi Breakdown of academic impact, for papers by Kuan-Chong Chao Breakdown of academic impact, for papers by Masamichi Hiura
Rankless by CCL
2026